GO:0006259 | DNA metabolic process | 18.02% (20/111) | 2.69 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 26.13% (29/111) | 1.84 | 0.0 | 1e-06 |
GO:0044260 | cellular macromolecule metabolic process | 28.83% (32/111) | 1.72 | 0.0 | 1e-06 |
GO:0043228 | non-membrane-bounded organelle | 27.93% (31/111) | 1.66 | 0.0 | 2e-06 |
GO:0043232 | intracellular non-membrane-bounded organelle | 27.93% (31/111) | 1.66 | 0.0 | 2e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 29.73% (33/111) | 1.56 | 0.0 | 2e-06 |
GO:0010629 | negative regulation of gene expression | 14.41% (16/111) | 2.58 | 0.0 | 2e-06 |
GO:0009892 | negative regulation of metabolic process | 26.13% (29/111) | 1.7 | 0.0 | 2e-06 |
GO:0140513 | nuclear protein-containing complex | 18.02% (20/111) | 2.24 | 0.0 | 2e-06 |
GO:0033043 | regulation of organelle organization | 14.41% (16/111) | 2.6 | 0.0 | 2e-06 |
GO:0090304 | nucleic acid metabolic process | 27.03% (30/111) | 1.71 | 0.0 | 2e-06 |
GO:0060255 | regulation of macromolecule metabolic process | 37.84% (42/111) | 1.26 | 0.0 | 3e-06 |
GO:0003676 | nucleic acid binding | 35.14% (39/111) | 1.27 | 0.0 | 1e-05 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 6.31% (7/111) | 4.26 | 0.0 | 1.6e-05 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 12.61% (14/111) | 2.56 | 0.0 | 2e-05 |
GO:0098687 | chromosomal region | 8.11% (9/111) | 3.48 | 0.0 | 2e-05 |
GO:0033044 | regulation of chromosome organization | 8.11% (9/111) | 3.41 | 0.0 | 2.8e-05 |
GO:0022402 | cell cycle process | 16.22% (18/111) | 2.08 | 0.0 | 3.1e-05 |
GO:2001251 | negative regulation of chromosome organization | 5.41% (6/111) | 4.48 | 0.0 | 4.2e-05 |
GO:0032204 | regulation of telomere maintenance | 5.41% (6/111) | 4.46 | 0.0 | 4.2e-05 |
GO:0070918 | small regulatory ncRNA processing | 6.31% (7/111) | 3.95 | 0.0 | 4.7e-05 |
GO:0051052 | regulation of DNA metabolic process | 9.91% (11/111) | 2.82 | 0.0 | 5.5e-05 |
GO:0032886 | regulation of microtubule-based process | 6.31% (7/111) | 3.88 | 1e-06 | 5.9e-05 |
GO:0006304 | DNA modification | 5.41% (6/111) | 4.25 | 1e-06 | 8e-05 |
GO:0051129 | negative regulation of cellular component organization | 9.01% (10/111) | 2.94 | 1e-06 | 8.3e-05 |
GO:0010639 | negative regulation of organelle organization | 7.21% (8/111) | 3.41 | 1e-06 | 8.5e-05 |
GO:0034641 | cellular nitrogen compound metabolic process | 31.53% (35/111) | 1.21 | 1e-06 | 8.8e-05 |
GO:0048523 | negative regulation of cellular process | 27.93% (31/111) | 1.32 | 1e-06 | 8.8e-05 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 4.5% (5/111) | 4.83 | 1e-06 | 9e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 12.61% (14/111) | 2.28 | 1e-06 | 9.5e-05 |
GO:0046483 | heterocycle metabolic process | 30.63% (34/111) | 1.22 | 1e-06 | 0.000102 |
GO:0051128 | regulation of cellular component organization | 18.92% (21/111) | 1.71 | 1e-06 | 0.000109 |
GO:0019222 | regulation of metabolic process | 38.74% (43/111) | 1.01 | 1e-06 | 0.000109 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 7.21% (8/111) | 3.32 | 2e-06 | 0.000111 |
GO:0005635 | nuclear envelope | 6.31% (7/111) | 3.61 | 2e-06 | 0.000134 |
GO:0031324 | negative regulation of cellular metabolic process | 18.92% (21/111) | 1.67 | 2e-06 | 0.000152 |
GO:1990234 | transferase complex | 12.61% (14/111) | 2.19 | 3e-06 | 0.000166 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 18.92% (21/111) | 1.64 | 3e-06 | 0.000171 |
GO:0032205 | negative regulation of telomere maintenance | 3.6% (4/111) | 5.37 | 3e-06 | 0.000172 |
GO:0006281 | DNA repair | 9.91% (11/111) | 2.56 | 3e-06 | 0.000174 |
GO:0032991 | protein-containing complex | 28.83% (32/111) | 1.22 | 3e-06 | 0.000177 |
GO:0010556 | regulation of macromolecule biosynthetic process | 26.13% (29/111) | 1.29 | 4e-06 | 0.00021 |
GO:0000419 | RNA polymerase V complex | 3.6% (4/111) | 5.25 | 4e-06 | 0.00021 |
GO:0016604 | nuclear body | 9.91% (11/111) | 2.51 | 4e-06 | 0.000211 |
GO:0006305 | DNA alkylation | 4.5% (5/111) | 4.41 | 4e-06 | 0.000214 |
GO:0006306 | DNA methylation | 4.5% (5/111) | 4.41 | 4e-06 | 0.000214 |
GO:0051054 | positive regulation of DNA metabolic process | 6.31% (7/111) | 3.47 | 4e-06 | 0.000214 |
GO:0000732 | strand displacement | 2.7% (3/111) | 6.46 | 5e-06 | 0.000245 |
GO:0048519 | negative regulation of biological process | 32.43% (36/111) | 1.08 | 5e-06 | 0.000267 |
GO:0030422 | siRNA processing | 4.5% (5/111) | 4.31 | 6e-06 | 0.000278 |
GO:0035198 | miRNA binding | 3.6% (4/111) | 5.1 | 6e-06 | 0.000281 |
GO:0010468 | regulation of gene expression | 28.83% (32/111) | 1.17 | 6e-06 | 0.000282 |
GO:1901363 | heterocyclic compound binding | 44.14% (49/111) | 0.83 | 6e-06 | 0.00029 |
GO:0051053 | negative regulation of DNA metabolic process | 5.41% (6/111) | 3.73 | 7e-06 | 0.000292 |
GO:0006282 | regulation of DNA repair | 5.41% (6/111) | 3.73 | 7e-06 | 0.000292 |
GO:2000779 | regulation of double-strand break repair | 4.5% (5/111) | 4.26 | 7e-06 | 0.000297 |
GO:0090063 | positive regulation of microtubule nucleation | 1.8% (2/111) | 8.46 | 8e-06 | 0.000301 |
GO:1904430 | negative regulation of t-circle formation | 1.8% (2/111) | 8.46 | 8e-06 | 0.000301 |
GO:1904535 | positive regulation of telomeric loop disassembly | 1.8% (2/111) | 8.46 | 8e-06 | 0.000301 |
GO:0071259 | cellular response to magnetism | 1.8% (2/111) | 8.46 | 8e-06 | 0.000301 |
GO:0080090 | regulation of primary metabolic process | 32.43% (36/111) | 1.06 | 7e-06 | 0.000302 |
GO:0099080 | supramolecular complex | 11.71% (13/111) | 2.16 | 7e-06 | 0.00031 |
GO:0005515 | protein binding | 58.56% (65/111) | 0.63 | 8e-06 | 0.000318 |
GO:0097159 | organic cyclic compound binding | 44.14% (49/111) | 0.83 | 8e-06 | 0.000319 |
GO:0044728 | DNA methylation or demethylation | 4.5% (5/111) | 4.21 | 8e-06 | 0.00032 |
GO:0031047 | gene silencing by RNA | 6.31% (7/111) | 3.27 | 9e-06 | 0.000327 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 14.41% (16/111) | 1.84 | 1e-05 | 0.000349 |
GO:0003950 | NAD+ ADP-ribosyltransferase activity | 2.7% (3/111) | 6.14 | 1e-05 | 0.000356 |
GO:0048522 | positive regulation of cellular process | 29.73% (33/111) | 1.1 | 1.1e-05 | 0.000385 |
GO:0051246 | regulation of protein metabolic process | 17.12% (19/111) | 1.63 | 1.1e-05 | 0.000386 |
GO:1904355 | positive regulation of telomere capping | 2.7% (3/111) | 6.04 | 1.2e-05 | 0.000407 |
GO:0051171 | regulation of nitrogen compound metabolic process | 30.63% (34/111) | 1.07 | 1.2e-05 | 0.000409 |
GO:0043414 | macromolecule methylation | 7.21% (8/111) | 2.91 | 1.2e-05 | 0.000411 |
GO:0005575 | cellular_component | 80.18% (89/111) | 0.39 | 1.2e-05 | 0.000412 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 3.6% (4/111) | 4.82 | 1.3e-05 | 0.000418 |
GO:0043170 | macromolecule metabolic process | 40.54% (45/111) | 0.86 | 1.3e-05 | 0.000423 |
GO:0061980 | regulatory RNA binding | 3.6% (4/111) | 4.68 | 1.9e-05 | 0.000567 |
GO:0001818 | negative regulation of cytokine production | 3.6% (4/111) | 4.68 | 1.9e-05 | 0.000567 |
GO:0032206 | positive regulation of telomere maintenance | 3.6% (4/111) | 4.68 | 1.9e-05 | 0.000567 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 9.91% (11/111) | 2.28 | 1.8e-05 | 0.000571 |
GO:0004386 | helicase activity | 6.31% (7/111) | 3.11 | 1.8e-05 | 0.000575 |
GO:0031327 | negative regulation of cellular biosynthetic process | 14.41% (16/111) | 1.75 | 2e-05 | 0.000604 |
GO:0071897 | DNA biosynthetic process | 4.5% (5/111) | 3.92 | 2.1e-05 | 0.00062 |
GO:0002828 | regulation of type 2 immune response | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:0002830 | positive regulation of type 2 immune response | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:0032651 | regulation of interleukin-1 beta production | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:0008275 | gamma-tubulin small complex | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:0010968 | regulation of microtubule nucleation | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:1902990 | mitotic telomere maintenance via semi-conservative replication | 1.8% (2/111) | 7.88 | 2.4e-05 | 0.00065 |
GO:0010608 | post-transcriptional regulation of gene expression | 9.91% (11/111) | 2.23 | 2.5e-05 | 0.000656 |
GO:1904353 | regulation of telomere capping | 2.7% (3/111) | 5.72 | 2.5e-05 | 0.000659 |
GO:1904356 | regulation of telomere maintenance via telomere lengthening | 3.6% (4/111) | 4.6 | 2.3e-05 | 0.000676 |
GO:0016570 | histone modification | 8.11% (9/111) | 2.54 | 2.6e-05 | 0.000686 |
GO:1902494 | catalytic complex | 15.32% (17/111) | 1.65 | 2.6e-05 | 0.000688 |
GO:0009890 | negative regulation of biosynthetic process | 14.41% (16/111) | 1.72 | 2.7e-05 | 0.000704 |
GO:0005488 | binding | 69.37% (77/111) | 0.47 | 2.8e-05 | 0.000723 |
GO:0032259 | methylation | 8.11% (9/111) | 2.51 | 3.1e-05 | 0.000787 |
GO:0018193 | peptidyl-amino acid modification | 10.81% (12/111) | 2.06 | 3.3e-05 | 0.000829 |
GO:0005694 | chromosome | 8.11% (9/111) | 2.48 | 3.7e-05 | 0.00091 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 24.32% (27/111) | 1.18 | 3.8e-05 | 0.000914 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 13.51% (15/111) | 1.75 | 3.7e-05 | 0.000916 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 19.82% (22/111) | 1.35 | 4e-05 | 0.000959 |
GO:0010604 | positive regulation of macromolecule metabolic process | 20.72% (23/111) | 1.31 | 4.1e-05 | 0.000965 |
GO:0006325 | chromatin organization | 7.21% (8/111) | 2.66 | 4.3e-05 | 0.001005 |
GO:0051493 | regulation of cytoskeleton organization | 6.31% (7/111) | 2.91 | 4.3e-05 | 0.001011 |
GO:0008094 | ATP-dependent activity, acting on DNA | 5.41% (6/111) | 3.24 | 4.4e-05 | 0.001022 |
GO:0000923 | equatorial microtubule organizing center | 1.8% (2/111) | 7.46 | 4.8e-05 | 0.001062 |
GO:1904429 | regulation of t-circle formation | 1.8% (2/111) | 7.46 | 4.8e-05 | 0.001062 |
GO:1904533 | regulation of telomeric loop disassembly | 1.8% (2/111) | 7.46 | 4.8e-05 | 0.001062 |
GO:0004614 | phosphoglucomutase activity | 1.8% (2/111) | 7.46 | 4.8e-05 | 0.001062 |
GO:0018205 | peptidyl-lysine modification | 7.21% (8/111) | 2.63 | 4.9e-05 | 0.001083 |
GO:0003678 | DNA helicase activity | 4.5% (5/111) | 3.66 | 5e-05 | 0.001094 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3.6% (4/111) | 4.29 | 5.5e-05 | 0.001181 |
GO:0140013 | meiotic nuclear division | 4.5% (5/111) | 3.61 | 5.9e-05 | 0.001271 |
GO:0031326 | regulation of cellular biosynthetic process | 26.13% (29/111) | 1.08 | 6.4e-05 | 0.001357 |
GO:0006725 | cellular aromatic compound metabolic process | 29.73% (33/111) | 0.98 | 6.5e-05 | 0.001367 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 4.5% (5/111) | 3.58 | 6.5e-05 | 0.001378 |
GO:0006974 | cellular response to DNA damage stimulus | 9.91% (11/111) | 2.06 | 6.9e-05 | 0.001429 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 5.41% (6/111) | 3.11 | 7.5e-05 | 0.001532 |
GO:0032495 | response to muramyl dipeptide | 1.8% (2/111) | 7.14 | 7.9e-05 | 0.001554 |
GO:0070716 | mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication | 1.8% (2/111) | 7.14 | 7.9e-05 | 0.001554 |
GO:1904505 | regulation of telomere maintenance in response to DNA damage | 1.8% (2/111) | 7.14 | 7.9e-05 | 0.001554 |
GO:1904506 | negative regulation of telomere maintenance in response to DNA damage | 1.8% (2/111) | 7.14 | 7.9e-05 | 0.001554 |
GO:0031965 | nuclear membrane | 5.41% (6/111) | 3.08 | 8.2e-05 | 0.001569 |
GO:0006471 | protein ADP-ribosylation | 2.7% (3/111) | 5.19 | 7.7e-05 | 0.001572 |
GO:0000018 | regulation of DNA recombination | 4.5% (5/111) | 3.52 | 8.1e-05 | 0.00158 |
GO:0006417 | regulation of translation | 8.11% (9/111) | 2.34 | 7.9e-05 | 0.001588 |
GO:0005819 | spindle | 5.41% (6/111) | 3.06 | 9.1e-05 | 0.001736 |
GO:2001020 | regulation of response to DNA damage stimulus | 5.41% (6/111) | 3.05 | 9.3e-05 | 0.00176 |
GO:0003723 | RNA binding | 17.12% (19/111) | 1.4 | 9.4e-05 | 0.001762 |
GO:1903046 | meiotic cell cycle process | 8.11% (9/111) | 2.3 | 9.4e-05 | 0.001767 |
GO:0051276 | chromosome organization | 7.21% (8/111) | 2.48 | 0.0001 | 0.001852 |
GO:0031325 | positive regulation of cellular metabolic process | 19.82% (22/111) | 1.26 | 0.000101 | 0.001855 |
GO:0009889 | regulation of biosynthetic process | 26.13% (29/111) | 1.03 | 0.000114 | 0.002071 |
GO:0009893 | positive regulation of metabolic process | 21.62% (24/111) | 1.17 | 0.000126 | 0.002287 |
GO:0031323 | regulation of cellular metabolic process | 30.63% (34/111) | 0.91 | 0.000128 | 0.00231 |
GO:0034248 | regulation of cellular amide metabolic process | 8.11% (9/111) | 2.24 | 0.00013 | 0.002311 |
GO:0140535 | intracellular protein-containing complex | 9.91% (11/111) | 1.93 | 0.000153 | 0.002708 |
GO:1901360 | organic cyclic compound metabolic process | 30.63% (34/111) | 0.89 | 0.000164 | 0.002883 |
GO:0000428 | DNA-directed RNA polymerase complex | 3.6% (4/111) | 3.88 | 0.000167 | 0.002901 |
GO:1904724 | tertiary granule lumen | 1.8% (2/111) | 6.65 | 0.000166 | 0.002904 |
GO:0048518 | positive regulation of biological process | 31.53% (35/111) | 0.87 | 0.000174 | 0.002947 |
GO:0008017 | microtubule binding | 5.41% (6/111) | 2.89 | 0.000173 | 0.002963 |
GO:0050789 | regulation of biological process | 50.45% (56/111) | 0.59 | 0.000173 | 0.002978 |
GO:0010305 | leaf vascular tissue pattern formation | 4.5% (5/111) | 3.27 | 0.000183 | 0.003081 |
GO:1901222 | regulation of NIK/NF-kappaB signaling | 2.7% (3/111) | 4.76 | 0.000189 | 0.003166 |
GO:0000922 | spindle pole | 3.6% (4/111) | 3.82 | 0.000196 | 0.00317 |
GO:0099081 | supramolecular polymer | 7.21% (8/111) | 2.34 | 0.000195 | 0.003183 |
GO:0099512 | supramolecular fiber | 7.21% (8/111) | 2.34 | 0.000195 | 0.003183 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 9.01% (10/111) | 2.01 | 0.000198 | 0.003193 |
GO:0000280 | nuclear division | 4.5% (5/111) | 3.25 | 0.000192 | 0.003196 |
GO:0110165 | cellular anatomical entity | 76.58% (85/111) | 0.35 | 0.000194 | 0.003203 |
GO:0031297 | replication fork processing | 2.7% (3/111) | 4.72 | 0.000204 | 0.003259 |
GO:0032652 | regulation of interleukin-1 production | 1.8% (2/111) | 6.46 | 0.000221 | 0.003424 |
GO:0043015 | gamma-tubulin binding | 1.8% (2/111) | 6.46 | 0.000221 | 0.003424 |
GO:0051011 | microtubule minus-end binding | 1.8% (2/111) | 6.46 | 0.000221 | 0.003424 |
GO:1903579 | negative regulation of ATP metabolic process | 1.8% (2/111) | 6.46 | 0.000221 | 0.003424 |
GO:0034739 | histone deacetylase activity (H4-K16 specific) | 1.8% (2/111) | 6.46 | 0.000221 | 0.003424 |
GO:0034660 | ncRNA metabolic process | 9.91% (11/111) | 1.86 | 0.000229 | 0.003526 |
GO:0030880 | RNA polymerase complex | 3.6% (4/111) | 3.75 | 0.000236 | 0.003608 |
GO:0043229 | intracellular organelle | 56.76% (63/111) | 0.51 | 0.000248 | 0.003768 |
GO:0051130 | positive regulation of cellular component organization | 8.11% (9/111) | 2.11 | 0.00026 | 0.003919 |
GO:0045980 | negative regulation of nucleotide metabolic process | 1.8% (2/111) | 6.29 | 0.000284 | 0.004158 |
GO:0070213 | protein auto-ADP-ribosylation | 1.8% (2/111) | 6.29 | 0.000284 | 0.004158 |
GO:1900543 | negative regulation of purine nucleotide metabolic process | 1.8% (2/111) | 6.29 | 0.000284 | 0.004158 |
GO:0071000 | response to magnetism | 1.8% (2/111) | 6.29 | 0.000284 | 0.004158 |
GO:0005874 | microtubule | 6.31% (7/111) | 2.48 | 0.000279 | 0.004183 |
GO:0065007 | biological regulation | 53.15% (59/111) | 0.53 | 0.000293 | 0.004234 |
GO:2001252 | positive regulation of chromosome organization | 3.6% (4/111) | 3.67 | 0.000292 | 0.004249 |
GO:0043226 | organelle | 56.76% (63/111) | 0.5 | 0.000298 | 0.004293 |
GO:0003674 | molecular_function | 75.68% (84/111) | 0.34 | 0.000306 | 0.004371 |
GO:0006351 | DNA-templated transcription | 4.5% (5/111) | 3.1 | 0.000309 | 0.004387 |
GO:0016573 | histone acetylation | 4.5% (5/111) | 3.1 | 0.000316 | 0.00446 |
GO:0031396 | regulation of protein ubiquitination | 4.5% (5/111) | 3.07 | 0.000337 | 0.004632 |
GO:0006475 | internal protein amino acid acetylation | 4.5% (5/111) | 3.07 | 0.000337 | 0.004632 |
GO:0018393 | internal peptidyl-lysine acetylation | 4.5% (5/111) | 3.07 | 0.000337 | 0.004632 |
GO:0031967 | organelle envelope | 9.91% (11/111) | 1.8 | 0.000333 | 0.004659 |
GO:0031975 | envelope | 9.91% (11/111) | 1.8 | 0.000333 | 0.004659 |
GO:0097659 | nucleic acid-templated transcription | 4.5% (5/111) | 3.07 | 0.000345 | 0.004682 |
GO:0018394 | peptidyl-lysine acetylation | 4.5% (5/111) | 3.07 | 0.000345 | 0.004682 |
GO:0042127 | regulation of cell population proliferation | 9.01% (10/111) | 1.91 | 0.000348 | 0.004696 |
GO:1900015 | regulation of cytokine production involved in inflammatory response | 1.8% (2/111) | 6.14 | 0.000354 | 0.004708 |
GO:0000930 | gamma-tubulin complex | 1.8% (2/111) | 6.14 | 0.000354 | 0.004708 |
GO:0043007 | maintenance of rDNA | 1.8% (2/111) | 6.14 | 0.000354 | 0.004708 |
GO:0031398 | positive regulation of protein ubiquitination | 3.6% (4/111) | 3.58 | 0.000368 | 0.004843 |
GO:0000152 | nuclear ubiquitin ligase complex | 2.7% (3/111) | 4.43 | 0.000373 | 0.004855 |
GO:0016779 | nucleotidyltransferase activity | 4.5% (5/111) | 3.05 | 0.000368 | 0.004861 |
GO:0005667 | transcription regulator complex | 5.41% (6/111) | 2.68 | 0.000373 | 0.004871 |
GO:0009141 | nucleoside triphosphate metabolic process | 4.5% (5/111) | 3.03 | 0.000384 | 0.004965 |
GO:0032467 | positive regulation of cytokinesis | 2.7% (3/111) | 4.4 | 0.000396 | 0.0051 |
GO:0032675 | regulation of interleukin-6 production | 1.8% (2/111) | 6.0 | 0.000432 | 0.005533 |
GO:0071840 | cellular component organization or biogenesis | 30.63% (34/111) | 0.82 | 0.000443 | 0.005636 |
GO:0006473 | protein acetylation | 4.5% (5/111) | 2.97 | 0.000472 | 0.005981 |
GO:0017148 | negative regulation of translation | 4.5% (5/111) | 2.95 | 0.000501 | 0.006286 |
GO:0000781 | chromosome, telomeric region | 3.6% (4/111) | 3.46 | 0.000501 | 0.006316 |
GO:0051716 | cellular response to stimulus | 27.03% (30/111) | 0.88 | 0.000551 | 0.006868 |
GO:0015631 | tubulin binding | 5.41% (6/111) | 2.57 | 0.000555 | 0.006891 |
GO:0140097 | catalytic activity, acting on DNA | 5.41% (6/111) | 2.56 | 0.000572 | 0.007024 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 14.41% (16/111) | 1.34 | 0.00057 | 0.007038 |
GO:0070212 | protein poly-ADP-ribosylation | 1.8% (2/111) | 5.76 | 0.000611 | 0.007356 |
GO:1990404 | NAD+-protein ADP-ribosyltransferase activity | 1.8% (2/111) | 5.76 | 0.000611 | 0.007356 |
GO:0070932 | histone H3 deacetylation | 1.8% (2/111) | 5.76 | 0.000611 | 0.007356 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.8% (2/111) | 5.76 | 0.000611 | 0.007356 |
GO:0022607 | cellular component assembly | 15.32% (17/111) | 1.27 | 0.000622 | 0.007414 |
GO:0034249 | negative regulation of cellular amide metabolic process | 4.5% (5/111) | 2.88 | 0.00062 | 0.007435 |
GO:0016043 | cellular component organization | 28.83% (32/111) | 0.82 | 0.000673 | 0.007987 |
GO:0044238 | primary metabolic process | 46.85% (52/111) | 0.56 | 0.000687 | 0.008119 |
GO:0071214 | cellular response to abiotic stimulus | 9.01% (10/111) | 1.77 | 0.000723 | 0.00826 |
GO:0104004 | cellular response to environmental stimulus | 9.01% (10/111) | 1.77 | 0.000723 | 0.00826 |
GO:0032494 | response to peptidoglycan | 1.8% (2/111) | 5.65 | 0.000711 | 0.00828 |
GO:0010445 | nuclear dicing body | 1.8% (2/111) | 5.65 | 0.000711 | 0.00828 |
GO:2000648 | positive regulation of stem cell proliferation | 1.8% (2/111) | 5.65 | 0.000711 | 0.00828 |
GO:0055028 | cortical microtubule | 3.6% (4/111) | 3.32 | 0.000721 | 0.00831 |
GO:0048285 | organelle fission | 4.5% (5/111) | 2.83 | 0.000719 | 0.008336 |
GO:0035861 | site of double-strand break | 2.7% (3/111) | 4.09 | 0.000746 | 0.008485 |
GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 2.7% (3/111) | 4.07 | 0.000782 | 0.008768 |
GO:0140657 | ATP-dependent activity | 8.11% (9/111) | 1.89 | 0.000781 | 0.008805 |
GO:0010638 | positive regulation of organelle organization | 5.41% (6/111) | 2.48 | 0.00078 | 0.008824 |
GO:0099513 | polymeric cytoskeletal fiber | 6.31% (7/111) | 2.22 | 0.0008 | 0.008929 |
GO:0070182 | DNA polymerase binding | 1.8% (2/111) | 5.55 | 0.000819 | 0.009103 |
GO:0009942 | longitudinal axis specification | 2.7% (3/111) | 4.02 | 0.000856 | 0.009475 |
GO:1901653 | cellular response to peptide | 3.6% (4/111) | 3.25 | 0.000863 | 0.009508 |
GO:0007276 | gamete generation | 5.41% (6/111) | 2.44 | 0.000891 | 0.00973 |
GO:0140098 | catalytic activity, acting on RNA | 7.21% (8/111) | 2.01 | 0.000891 | 0.009766 |
GO:0031116 | positive regulation of microtubule polymerization | 1.8% (2/111) | 5.46 | 0.000934 | 0.00989 |
GO:0006277 | DNA amplification | 1.8% (2/111) | 5.46 | 0.000934 | 0.00989 |
GO:0072091 | regulation of stem cell proliferation | 1.8% (2/111) | 5.46 | 0.000934 | 0.00989 |
GO:0010313 | phytochrome binding | 1.8% (2/111) | 5.46 | 0.000934 | 0.00989 |
GO:0003714 | transcription corepressor activity | 3.6% (4/111) | 3.22 | 0.00093 | 0.010018 |
GO:0006996 | organelle organization | 17.12% (19/111) | 1.13 | 0.000927 | 0.010034 |
GO:0034470 | ncRNA processing | 8.11% (9/111) | 1.85 | 0.000926 | 0.01006 |
GO:0045910 | negative regulation of DNA recombination | 2.7% (3/111) | 3.96 | 0.000977 | 0.010291 |
GO:0044265 | cellular macromolecule catabolic process | 9.01% (10/111) | 1.7 | 0.001071 | 0.011241 |
GO:0019899 | enzyme binding | 13.51% (15/111) | 1.3 | 0.00109 | 0.011394 |
GO:0008150 | biological_process | 75.68% (84/111) | 0.3 | 0.001137 | 0.011834 |
GO:1903047 | mitotic cell cycle process | 7.21% (8/111) | 1.95 | 0.001154 | 0.011905 |
GO:0043543 | protein acylation | 4.5% (5/111) | 2.68 | 0.001161 | 0.011925 |
GO:0035967 | cellular response to topologically incorrect protein | 2.7% (3/111) | 3.88 | 0.001153 | 0.011941 |
GO:0043570 | maintenance of DNA repeat elements | 1.8% (2/111) | 5.29 | 0.001187 | 0.012042 |
GO:0016529 | sarcoplasmic reticulum | 1.8% (2/111) | 5.29 | 0.001187 | 0.012042 |
GO:0051252 | regulation of RNA metabolic process | 19.82% (22/111) | 1.0 | 0.001193 | 0.012055 |
GO:0005881 | cytoplasmic microtubule | 3.6% (4/111) | 3.13 | 0.001179 | 0.012064 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 2.7% (3/111) | 3.84 | 0.001248 | 0.012553 |
GO:0046034 | ATP metabolic process | 3.6% (4/111) | 3.1 | 0.001262 | 0.012648 |
GO:0042325 | regulation of phosphorylation | 6.31% (7/111) | 2.11 | 0.001269 | 0.012668 |
GO:0009785 | blue light signaling pathway | 2.7% (3/111) | 3.82 | 0.001297 | 0.012838 |
GO:0048856 | anatomical structure development | 32.43% (36/111) | 0.7 | 0.001304 | 0.012851 |
GO:0031399 | regulation of protein modification process | 9.01% (10/111) | 1.66 | 0.001295 | 0.012876 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 1.8% (2/111) | 5.21 | 0.001324 | 0.01295 |
GO:0019896 | axonal transport of mitochondrion | 1.8% (2/111) | 5.21 | 0.001324 | 0.01295 |
GO:0019220 | regulation of phosphate metabolic process | 7.21% (8/111) | 1.92 | 0.001335 | 0.013005 |
GO:0080135 | regulation of cellular response to stress | 7.21% (8/111) | 1.91 | 0.001381 | 0.013397 |
GO:0009059 | macromolecule biosynthetic process | 10.81% (12/111) | 1.46 | 0.001405 | 0.013576 |
GO:0009987 | cellular process | 66.67% (74/111) | 0.35 | 0.001414 | 0.013616 |
GO:0002718 | regulation of cytokine production involved in immune response | 1.8% (2/111) | 5.14 | 0.001468 | 0.013757 |
GO:0032680 | regulation of tumor necrosis factor production | 1.8% (2/111) | 5.14 | 0.001468 | 0.013757 |
GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 1.8% (2/111) | 5.14 | 0.001468 | 0.013757 |
GO:0090571 | RNA polymerase II transcription repressor complex | 1.8% (2/111) | 5.14 | 0.001468 | 0.013757 |
GO:0001649 | osteoblast differentiation | 1.8% (2/111) | 5.14 | 0.001468 | 0.013757 |
GO:0051174 | regulation of phosphorus metabolic process | 7.21% (8/111) | 1.89 | 0.001476 | 0.013774 |
GO:0007049 | cell cycle | 6.31% (7/111) | 2.07 | 0.001486 | 0.013811 |
GO:0090734 | site of DNA damage | 2.7% (3/111) | 3.76 | 0.001452 | 0.013869 |
GO:0048869 | cellular developmental process | 16.22% (18/111) | 1.12 | 0.001448 | 0.013886 |
GO:0006807 | nitrogen compound metabolic process | 41.44% (46/111) | 0.57 | 0.001499 | 0.013887 |
GO:0047497 | mitochondrion transport along microtubule | 1.8% (2/111) | 5.07 | 0.00162 | 0.014725 |
GO:0004407 | histone deacetylase activity | 1.8% (2/111) | 5.07 | 0.00162 | 0.014725 |
GO:0033558 | protein lysine deacetylase activity | 1.8% (2/111) | 5.07 | 0.00162 | 0.014725 |
GO:0016868 | intramolecular transferase activity, phosphotransferases | 1.8% (2/111) | 5.07 | 0.00162 | 0.014725 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 3.6% (4/111) | 3.01 | 0.001602 | 0.014778 |
GO:0008047 | enzyme activator activity | 4.5% (5/111) | 2.56 | 0.001652 | 0.014964 |
GO:0005654 | nucleoplasm | 11.71% (13/111) | 1.36 | 0.00168 | 0.015161 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4.5% (5/111) | 2.55 | 0.001701 | 0.015294 |
GO:0031331 | positive regulation of cellular catabolic process | 5.41% (6/111) | 2.25 | 0.001725 | 0.015445 |
GO:0051646 | mitochondrion localization | 2.7% (3/111) | 3.67 | 0.001736 | 0.01549 |
GO:0009303 | rRNA transcription | 1.8% (2/111) | 5.0 | 0.001779 | 0.015815 |
GO:0034062 | 5'-3' RNA polymerase activity | 2.7% (3/111) | 3.65 | 0.001797 | 0.015915 |
GO:0048468 | cell development | 7.21% (8/111) | 1.85 | 0.001808 | 0.015956 |
GO:0009638 | phototropism | 2.7% (3/111) | 3.64 | 0.001858 | 0.016345 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 3.6% (4/111) | 2.94 | 0.001885 | 0.016522 |
GO:0006606 | protein import into nucleus | 2.7% (3/111) | 3.62 | 0.001922 | 0.01678 |
GO:0050728 | negative regulation of inflammatory response | 1.8% (2/111) | 4.94 | 0.001945 | 0.01686 |
GO:0031114 | regulation of microtubule depolymerization | 1.8% (2/111) | 4.94 | 0.001945 | 0.01686 |
GO:0031329 | regulation of cellular catabolic process | 7.21% (8/111) | 1.83 | 0.001986 | 0.016923 |
GO:0001817 | regulation of cytokine production | 3.6% (4/111) | 2.93 | 0.001961 | 0.016945 |
GO:0097747 | RNA polymerase activity | 2.7% (3/111) | 3.6 | 0.001986 | 0.01698 |
GO:0035196 | miRNA processing | 2.7% (3/111) | 3.6 | 0.001986 | 0.01698 |
GO:0007507 | heart development | 2.7% (3/111) | 3.6 | 0.001986 | 0.01698 |
GO:0006355 | regulation of DNA-templated transcription | 18.02% (20/111) | 1.0 | 0.002051 | 0.017408 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 3.6% (4/111) | 2.91 | 0.002079 | 0.017591 |
GO:0050794 | regulation of cellular process | 42.34% (47/111) | 0.54 | 0.002105 | 0.017751 |
GO:1903506 | regulation of nucleic acid-templated transcription | 18.02% (20/111) | 1.0 | 0.00212 | 0.017753 |
GO:0031113 | regulation of microtubule polymerization | 1.8% (2/111) | 4.88 | 0.002117 | 0.017791 |
GO:2001141 | regulation of RNA biosynthetic process | 18.02% (20/111) | 1.0 | 0.002134 | 0.017811 |
GO:0031122 | cytoplasmic microtubule organization | 3.6% (4/111) | 2.89 | 0.00216 | 0.017967 |
GO:0051781 | positive regulation of cell division | 2.7% (3/111) | 3.55 | 0.002188 | 0.018134 |
GO:0031072 | heat shock protein binding | 3.6% (4/111) | 2.88 | 0.002244 | 0.018535 |
GO:0034643 | establishment of mitochondrion localization, microtubule-mediated | 1.8% (2/111) | 4.82 | 0.002297 | 0.018786 |
GO:0000418 | RNA polymerase IV complex | 1.8% (2/111) | 4.82 | 0.002297 | 0.018786 |
GO:0071218 | cellular response to misfolded protein | 1.8% (2/111) | 4.82 | 0.002297 | 0.018786 |
GO:0000578 | embryonic axis specification | 2.7% (3/111) | 3.52 | 0.002329 | 0.018983 |
GO:0016571 | histone methylation | 3.6% (4/111) | 2.85 | 0.002373 | 0.019278 |
GO:0006260 | DNA replication | 3.6% (4/111) | 2.85 | 0.002417 | 0.019572 |
GO:0000900 | mRNA regulatory element binding translation repressor activity | 1.8% (2/111) | 4.76 | 0.002484 | 0.019784 |
GO:0051654 | establishment of mitochondrion localization | 1.8% (2/111) | 4.76 | 0.002484 | 0.019784 |
GO:0072699 | protein localization to cortical microtubule cytoskeleton | 1.8% (2/111) | 4.76 | 0.002484 | 0.019784 |
GO:0042826 | histone deacetylase binding | 2.7% (3/111) | 3.49 | 0.002476 | 0.019914 |
GO:0007140 | male meiotic nuclear division | 2.7% (3/111) | 3.49 | 0.002476 | 0.019914 |
GO:0005542 | folic acid binding | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0060574 | intestinal epithelial cell maturation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0070318 | positive regulation of G0 to G1 transition | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0031687 | A2A adenosine receptor binding | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0007072 | positive regulation of transcription involved in exit from mitosis | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0031940 | obsolete positive regulation of chromatin silencing at telomere | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0032129 | histone deacetylase activity (H3-K9 specific) | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0036048 | protein desuccinylation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0036049 | peptidyl-lysine desuccinylation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0036055 | protein-succinyllysine desuccinylase activity | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0046969 | NAD-dependent histone deacetylase activity (H3-K9 specific) | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0061697 | protein-glutaryllysine deglutarylase activity | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0061698 | protein deglutarylation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0097372 | NAD-dependent histone deacetylase activity (H3-K18 specific) | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0106230 | protein depropionylation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0106231 | protein-propionyllysine depropionylase activity | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1902732 | positive regulation of chondrocyte proliferation | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1905332 | positive regulation of morphogenesis of an epithelium | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1905549 | obsolete positive regulation of subtelomeric heterochromatin assembly | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1905553 | regulation of blood vessel branching | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1905555 | positive regulation of blood vessel branching | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0019961 | interferon binding | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0019964 | interferon-gamma binding | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1990390 | protein K33-linked ubiquitination | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0000714 | meiotic strand displacement | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1902346 | meiotic strand displacement involved in double-strand break repair via SDSA | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0035118 | embryonic pectoral fin morphogenesis | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0071600 | otic vesicle morphogenesis | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1902606 | regulation of large conductance calcium-activated potassium channel activity | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:1902607 | negative regulation of large conductance calcium-activated potassium channel activity | 0.9% (1/111) | 8.46 | 0.00284 | 0.020009 |
GO:0044877 | protein-containing complex binding | 8.11% (9/111) | 1.61 | 0.002851 | 0.020028 |
GO:0005680 | anaphase-promoting complex | 1.8% (2/111) | 4.65 | 0.002879 | 0.020166 |
GO:0051253 | negative regulation of RNA metabolic process | 9.91% (11/111) | 1.44 | 0.002563 | 0.020345 |
GO:0071483 | cellular response to blue light | 2.7% (3/111) | 3.46 | 0.002628 | 0.020664 |
GO:0000118 | histone deacetylase complex | 2.7% (3/111) | 3.46 | 0.002628 | 0.020664 |
GO:0043967 | histone H4 acetylation | 2.7% (3/111) | 3.46 | 0.002628 | 0.020664 |
GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 1.8% (2/111) | 4.71 | 0.002678 | 0.020985 |
GO:1902903 | regulation of supramolecular fiber organization | 3.6% (4/111) | 2.8 | 0.002695 | 0.02105 |
GO:0003682 | chromatin binding | 6.31% (7/111) | 1.91 | 0.00272 | 0.021179 |
GO:0016581 | NuRD complex | 1.8% (2/111) | 4.6 | 0.003086 | 0.021255 |
GO:0090545 | CHD-type complex | 1.8% (2/111) | 4.6 | 0.003086 | 0.021255 |
GO:1904357 | negative regulation of telomere maintenance via telomere lengthening | 1.8% (2/111) | 4.6 | 0.003086 | 0.021255 |
GO:0019213 | deacetylase activity | 1.8% (2/111) | 4.6 | 0.003086 | 0.021255 |
GO:0006338 | chromatin remodeling | 4.5% (5/111) | 2.36 | 0.003071 | 0.021393 |
GO:0009057 | macromolecule catabolic process | 9.91% (11/111) | 1.4 | 0.003065 | 0.021413 |
GO:0006396 | RNA processing | 10.81% (12/111) | 1.32 | 0.003121 | 0.021433 |
GO:0043488 | regulation of mRNA stability | 3.6% (4/111) | 2.79 | 0.002792 | 0.021669 |
GO:0008284 | positive regulation of cell population proliferation | 5.41% (6/111) | 2.11 | 0.002816 | 0.021785 |
GO:0003729 | mRNA binding | 10.81% (12/111) | 1.34 | 0.002835 | 0.021863 |
GO:0072686 | mitotic spindle | 2.7% (3/111) | 3.36 | 0.003207 | 0.021964 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 12.61% (14/111) | 1.19 | 0.003279 | 0.022396 |
GO:0072697 | protein localization to cell cortex | 1.8% (2/111) | 4.55 | 0.0033 | 0.022415 |
GO:0051247 | positive regulation of protein metabolic process | 8.11% (9/111) | 1.58 | 0.003294 | 0.022432 |
GO:0051248 | negative regulation of protein metabolic process | 7.21% (8/111) | 1.7 | 0.00335 | 0.022686 |
GO:0051013 | microtubule severing | 1.8% (2/111) | 4.51 | 0.003521 | 0.023654 |
GO:0016584 | obsolete nucleosome positioning | 1.8% (2/111) | 4.51 | 0.003521 | 0.023654 |
GO:0051788 | response to misfolded protein | 1.8% (2/111) | 4.51 | 0.003521 | 0.023654 |
GO:0051240 | positive regulation of multicellular organismal process | 8.11% (9/111) | 1.56 | 0.003546 | 0.02375 |
GO:0007281 | germ cell development | 3.6% (4/111) | 2.68 | 0.003656 | 0.024422 |
GO:0031334 | positive regulation of protein-containing complex assembly | 2.7% (3/111) | 3.28 | 0.00376 | 0.024916 |
GO:0032465 | regulation of cytokinesis | 2.7% (3/111) | 3.28 | 0.00376 | 0.024916 |
GO:0005665 | RNA polymerase II, core complex | 1.8% (2/111) | 4.46 | 0.003749 | 0.024978 |
GO:0050790 | regulation of catalytic activity | 9.01% (10/111) | 1.45 | 0.003824 | 0.025267 |
GO:0031328 | positive regulation of cellular biosynthetic process | 13.51% (15/111) | 1.11 | 0.003882 | 0.025587 |
GO:0007283 | spermatogenesis | 3.6% (4/111) | 2.65 | 0.003897 | 0.025615 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 1.8% (2/111) | 4.42 | 0.003984 | 0.025975 |
GO:0032273 | positive regulation of protein polymerization | 1.8% (2/111) | 4.42 | 0.003984 | 0.025975 |
GO:0071478 | cellular response to radiation | 5.41% (6/111) | 2.01 | 0.003979 | 0.026082 |
GO:0043487 | regulation of RNA stability | 3.6% (4/111) | 2.64 | 0.004022 | 0.026153 |
GO:0051170 | import into nucleus | 2.7% (3/111) | 3.24 | 0.004058 | 0.026245 |
GO:0006261 | DNA-templated DNA replication | 2.7% (3/111) | 3.24 | 0.004058 | 0.026245 |
GO:0000278 | mitotic cell cycle | 2.7% (3/111) | 3.22 | 0.00416 | 0.026835 |
GO:0051726 | regulation of cell cycle | 8.11% (9/111) | 1.53 | 0.004192 | 0.026975 |
GO:0032774 | RNA biosynthetic process | 4.5% (5/111) | 2.25 | 0.004229 | 0.026997 |
GO:0036297 | interstrand cross-link repair | 1.8% (2/111) | 4.37 | 0.004225 | 0.027042 |
GO:0051211 | anisotropic cell growth | 1.8% (2/111) | 4.37 | 0.004225 | 0.027042 |
GO:0000792 | heterochromatin | 2.7% (3/111) | 3.2 | 0.004369 | 0.027744 |
GO:0048513 | animal organ development | 8.11% (9/111) | 1.52 | 0.004368 | 0.02781 |
GO:0009891 | positive regulation of biosynthetic process | 13.51% (15/111) | 1.09 | 0.004559 | 0.028727 |
GO:0018130 | heterocycle biosynthetic process | 10.81% (12/111) | 1.25 | 0.00455 | 0.028745 |
GO:0061013 | regulation of mRNA catabolic process | 3.6% (4/111) | 2.59 | 0.004547 | 0.028805 |
GO:0008092 | cytoskeletal protein binding | 6.31% (7/111) | 1.77 | 0.004625 | 0.029068 |
GO:0032392 | DNA geometric change | 2.7% (3/111) | 3.16 | 0.004694 | 0.029426 |
GO:0048487 | beta-tubulin binding | 1.8% (2/111) | 4.29 | 0.004727 | 0.029484 |
GO:0046825 | regulation of protein export from nucleus | 1.8% (2/111) | 4.29 | 0.004727 | 0.029484 |
GO:0009896 | positive regulation of catabolic process | 5.41% (6/111) | 1.95 | 0.004804 | 0.029887 |
GO:0006302 | double-strand break repair | 3.6% (4/111) | 2.56 | 0.004898 | 0.030398 |
GO:0006479 | protein methylation | 3.6% (4/111) | 2.55 | 0.004971 | 0.030691 |
GO:0008213 | protein alkylation | 3.6% (4/111) | 2.55 | 0.004971 | 0.030691 |
GO:0003730 | mRNA 3'-UTR binding | 2.7% (3/111) | 3.1 | 0.005268 | 0.03236 |
GO:0043014 | alpha-tubulin binding | 1.8% (2/111) | 4.21 | 0.005255 | 0.032367 |
GO:0050307 | sucrose-phosphate phosphatase activity | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0008703 | 5-amino-6-(5-phosphoribosylamino)uracil reductase activity | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0008835 | diaminohydroxyphosphoribosylaminopyrimidine deaminase activity | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0002070 | epithelial cell maturation | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0009256 | 10-formyltetrahydrofolate metabolic process | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0009257 | 10-formyltetrahydrofolate biosynthetic process | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0010621 | negative regulation of transcription by transcription factor localization | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0010832 | negative regulation of myotube differentiation | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0061734 | parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0070823 | HDA1 complex | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0070844 | polyubiquitinated protein transport | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0070845 | polyubiquitinated misfolded protein transport | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:1901033 | positive regulation of response to reactive oxygen species | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:1905206 | positive regulation of hydrogen peroxide-induced cell death | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:1990342 | heterochromatin island | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:1905564 | positive regulation of vascular endothelial cell proliferation | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0035641 | locomotory exploration behavior | 0.9% (1/111) | 7.46 | 0.005672 | 0.032938 |
GO:0003677 | DNA binding | 16.22% (18/111) | 0.94 | 0.00541 | 0.033151 |
GO:0005730 | nucleolus | 9.01% (10/111) | 1.37 | 0.005425 | 0.033162 |
GO:0035097 | histone methyltransferase complex | 2.7% (3/111) | 3.06 | 0.005756 | 0.03319 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4.5% (5/111) | 2.14 | 0.005729 | 0.033191 |
GO:0051254 | positive regulation of RNA metabolic process | 11.71% (13/111) | 1.15 | 0.005755 | 0.033263 |
GO:0051641 | cellular localization | 12.61% (14/111) | 1.09 | 0.005834 | 0.033563 |
GO:0009798 | axis specification | 2.7% (3/111) | 3.08 | 0.005508 | 0.033586 |
GO:0035966 | response to topologically incorrect protein | 2.7% (3/111) | 3.04 | 0.005882 | 0.033758 |
GO:0071417 | cellular response to organonitrogen compound | 4.5% (5/111) | 2.15 | 0.005552 | 0.03377 |
GO:0003727 | single-stranded RNA binding | 3.6% (4/111) | 2.48 | 0.005977 | 0.034224 |
GO:0005876 | spindle microtubule | 2.7% (3/111) | 3.03 | 0.006009 | 0.03433 |
GO:0043254 | regulation of protein-containing complex assembly | 3.6% (4/111) | 2.47 | 0.006059 | 0.034535 |
GO:0098930 | axonal transport | 1.8% (2/111) | 4.1 | 0.006096 | 0.034583 |
GO:0035770 | ribonucleoprotein granule | 4.5% (5/111) | 2.12 | 0.006093 | 0.034647 |
GO:0003724 | RNA helicase activity | 2.7% (3/111) | 3.02 | 0.006139 | 0.034744 |
GO:0048232 | male gamete generation | 3.6% (4/111) | 2.46 | 0.006227 | 0.035161 |
GO:0044087 | regulation of cellular component biogenesis | 6.31% (7/111) | 1.69 | 0.006293 | 0.035452 |
GO:0016070 | RNA metabolic process | 12.61% (14/111) | 1.08 | 0.006374 | 0.035824 |
GO:0046822 | regulation of nucleocytoplasmic transport | 2.7% (3/111) | 3.0 | 0.006403 | 0.035905 |
GO:0048812 | neuron projection morphogenesis | 2.7% (3/111) | 2.98 | 0.006673 | 0.037336 |
GO:0048562 | embryonic organ morphogenesis | 1.8% (2/111) | 4.03 | 0.006689 | 0.037337 |
GO:0071103 | DNA conformation change | 2.7% (3/111) | 2.97 | 0.006811 | 0.037933 |
GO:0097435 | supramolecular fiber organization | 4.5% (5/111) | 2.08 | 0.006871 | 0.038181 |
GO:0051983 | regulation of chromosome segregation | 2.7% (3/111) | 2.96 | 0.00695 | 0.038188 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.7% (3/111) | 2.96 | 0.00695 | 0.038188 |
GO:0048858 | cell projection morphogenesis | 2.7% (3/111) | 2.96 | 0.00695 | 0.038188 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 2.7% (3/111) | 2.96 | 0.00695 | 0.038188 |
GO:0006357 | regulation of transcription by RNA polymerase II | 9.01% (10/111) | 1.32 | 0.006899 | 0.038251 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.8% (2/111) | 4.0 | 0.006994 | 0.038343 |
GO:0000723 | telomere maintenance | 2.7% (3/111) | 2.95 | 0.007091 | 0.038702 |
GO:0032200 | telomere organization | 2.7% (3/111) | 2.95 | 0.007091 | 0.038702 |
GO:0042393 | histone binding | 3.6% (4/111) | 2.4 | 0.00711 | 0.038719 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 1.8% (2/111) | 3.97 | 0.007306 | 0.039608 |
GO:0006094 | gluconeogenesis | 1.8% (2/111) | 3.97 | 0.007306 | 0.039608 |
GO:0030522 | intracellular receptor signaling pathway | 2.7% (3/111) | 2.92 | 0.007525 | 0.040705 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.8% (2/111) | 3.94 | 0.007624 | 0.04115 |
GO:1902532 | negative regulation of intracellular signal transduction | 4.5% (5/111) | 2.04 | 0.007643 | 0.041159 |
GO:0071704 | organic substance metabolic process | 48.65% (54/111) | 0.39 | 0.00793 | 0.042611 |
GO:0004146 | dihydrofolate reductase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0004799 | thymidylate synthase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0043846 | DNA polymerase III, clamp loader complex | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0040035 | hermaphrodite genitalia development | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0045138 | nematode male tail tip morphogenesis | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0033566 | gamma-tubulin complex localization | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0071770 | DIM/DIP cell wall layer assembly | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0002076 | osteoblast development | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0047611 | acetylspermidine deacetylase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0048668 | collateral sprouting | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0051004 | regulation of lipoprotein lipase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0061333 | renal tubule morphogenesis | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0070846 | Hsp90 deacetylation | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0071498 | cellular response to fluid shear stress | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0106047 | polyamine deacetylation | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0106048 | spermidine deacetylation | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:1900443 | regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:1900445 | positive regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:1990678 | histone H4-K16 deacetylation | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0043150 | DNA synthesis involved in double-strand break repair via homologous recombination | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:1905775 | negative regulation of DNA helicase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0046920 | alpha-(1->3)-fucosyltransferase activity | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0010829 | negative regulation of glucose transmembrane transport | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0046325 | negative regulation of glucose import | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0031436 | BRCA1-BARD1 complex | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0042794 | plastid rRNA transcription | 0.9% (1/111) | 6.88 | 0.008495 | 0.042651 |
GO:0009894 | regulation of catabolic process | 7.21% (8/111) | 1.47 | 0.008536 | 0.042681 |
GO:1902531 | regulation of intracellular signal transduction | 7.21% (8/111) | 1.47 | 0.008536 | 0.042681 |
GO:0006298 | mismatch repair | 1.8% (2/111) | 3.85 | 0.008615 | 0.042987 |
GO:0008186 | ATP-dependent activity, acting on RNA | 2.7% (3/111) | 2.88 | 0.008127 | 0.043575 |
GO:0006284 | base-excision repair | 1.8% (2/111) | 3.88 | 0.008279 | 0.044098 |
GO:0071014 | post-mRNA release spliceosomal complex | 1.8% (2/111) | 3.88 | 0.008279 | 0.044098 |
GO:0032502 | developmental process | 37.84% (42/111) | 0.49 | 0.008246 | 0.044115 |
GO:0051701 | biological process involved in interaction with host | 2.7% (3/111) | 2.83 | 0.008918 | 0.044229 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.7% (3/111) | 2.83 | 0.008918 | 0.044229 |
GO:0032990 | cell part morphogenesis | 2.7% (3/111) | 2.83 | 0.008918 | 0.044229 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 10.81% (12/111) | 1.12 | 0.00918 | 0.045435 |
GO:0044237 | cellular metabolic process | 45.05% (50/111) | 0.41 | 0.009526 | 0.047052 |
GO:0034708 | methyltransferase complex | 2.7% (3/111) | 2.78 | 0.009753 | 0.048078 |
GO:0000151 | ubiquitin ligase complex | 4.5% (5/111) | 1.95 | 0.009876 | 0.048585 |
GO:0016763 | pentosyltransferase activity | 2.7% (3/111) | 2.77 | 0.009925 | 0.048731 |
GO:0016575 | histone deacetylation | 1.8% (2/111) | 3.73 | 0.010021 | 0.049001 |
GO:0030018 | Z disc | 1.8% (2/111) | 3.73 | 0.010021 | 0.049001 |